Daewoong Pharmaceutical submits a new drug application for Fexuprazan in China challenging the…
– Daewoong Pharmaceutical, "Expecting the smooth approval with the successful phase 3 clinical trial in China aiming to reach 100 countries by 2027"
SEOUL, South Korea, July 31, 2023 /PRNewswire/ -- Daewoong Pharmaceutical's domestically…